Clinical Trials Directory

Trials / Completed

CompletedNCT00541684

Health Assessment Study (0954-946)

A Randomized, Double-Blind, Two Arm, Parallel Group Health Assessment Study of Losartan or Atenolol in Patients With Mild to Moderate Hypertension

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
143 (actual)
Sponsor
Organon and Co · Industry
Sex
Male
Age
40 Years – 49 Years
Healthy volunteers
Not accepted

Summary

The study will look at the effects of losartan or atenolol on frequency of sexual intercourse in subjects with newly diagnosed mild to moderate hypertension.

Conditions

Interventions

TypeNameDescription
DRUGMK0954, /Duration of Treatment : 16 Weeks
DRUGComparator : atenolol /Duration of Treatment : 16 Weeks

Timeline

Start date
2001-07-11
Primary completion
2003-01-23
Completion
2003-01-23
First posted
2007-10-10
Last updated
2024-08-15

Source: ClinicalTrials.gov record NCT00541684. Inclusion in this directory is not an endorsement.